Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Cholesterol

    Client Email Product

    Cholesterol

    APIs // Active Pharmaceutical Ingredients

    PRICE INFORMATION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    MARKET PLACE

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Related ProductsRelated Products
    API SUPPLIERS
    API Suppliers

    API Suppliers

    19
    US DMFs Filed

    US DMFs Filed

    6
    CEP/COS Certifications

    CEP/COS Certifications

    7
    JDMFs Filed

    JDMFs Filed

    2
    Other Certificates

    Other Certificates

    1
    Other Suppliers

    Other Suppliers

    6
    API REF. PRICE (USD / KG)
    17,145

    API Market Place

    10
    INTERMEDIATES

    0

    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    0

    Europe

    Europe

    0

    Canada

    Canada

    0

    Australia

    Australia

    0

    South Africa

    South Africa

    0

    Uploaded Dossiers

    Uploaded Dossiers

    0

    GLOBAL SALES (USD Million)

    U.S. Medicaid

    0

    Annual Reports

    0

    FDF Market Place

    0

    EXCIPIENTS
    24
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    0

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    2

    News

    27
    REF STANDARD

    EDQM

    2

    USP

    1

    JP

    0

    Other Listed Suppliers

    1
    SERVICES

    0

    Full View ScreenFull Screen View
    FDA rebukes small biotech Althera for promotional claims
    FDA rebukes small biotech Althera for promotional claims

    https://www.fiercepharma.com/marketing/fda-rebukes-small-biotech-althera-promotional-claims-its-cholesterol-combo-drug

    Ben Adams FIERCEPHARMA
    13 Jun 2022
    Share Share
    Pharma patent appeals dismissed by Court of Appeal
    Pharma patent appeals dismissed by Court of Appeal

    https://www.irishtimes.com/business/health-pharma/pharma-patent-appeals-dismissed-by-court-of-appeal-1.4787269

    IRISHTIMES
    28 Jan 2022
    Share Share
    Novartis wins FDA approval for new heart drug, but faces uphill sales battle
    Novartis wins FDA approval for new heart drug, but faces uphill sales battle

    https://www.biopharmadive.com/news/novartis-leqvio-inclisiran-fda-approval-cholesterol-heart/611170/

    J. Gardner BIOPHARMADIVE
    23 Dec 2021
    Share Share
    Amgen seeks SCOTUS review of long-running PCSK9 patent fight
    Amgen seeks SCOTUS review of long-running PCSK9 patent fight

    https://www.fiercepharma.com/pharma/amgen-takes-high-profile-pcsk9-patent-fight-sanofi-and-regeneron-to-supreme-court

    Fraiser Kansteiner FIERCEPHARMA
    30 Nov 2021
    Share Share
    SEC refuses local trial waiver for Novartis’ inclisiran injection
    SEC refuses local trial waiver for Novartis’ inclisiran injection

    http://www.pharmabiz.com/NewsDetails.aspx?aid=143482&sid=1

    PHARMABIZ
    26 Oct 2021
    Share Share
    Esperion to cute 170 staffers as heart disease pill sputters
    Esperion to cute 170 staffers as heart disease pill sputters

    https://finance.yahoo.com/finance/news/esperion-chops-40-workforce-launch-215424232.html

    V. Singh YAHOOFINANCE
    19 Oct 2021
    Share Share
    Kaiser sues big drugmakers around delayed generics
    Kaiser sues big drugmakers around delayed generics

    https://www.bizjournals.com/sanfrancisco/news/2021/07/28/kaiser-merck-cholesterol-zetia-vitorin-generic.html

    BIZJOURNALS
    02 Aug 2021
    Share Share
    FDA requests removal of warning against using cholesterol-lowering statins
    FDA requests removal of warning against using cholesterol-lowering statins

    https://www.fda.gov/drugs/drug-safety-and-availability/fda-requests-removal-strongest-warning-against-using-cholesterol-lowering-statins-during-pregnancy

    FDA
    20 Jul 2021
    Share Share
    Madrigal Pharma Offers Patients Resmetirom in Phase 3 MAESTRO-NAFLD-1 Study
    Madrigal Pharma Offers Patients Resmetirom in Phase 3 MAESTRO-NAFLD-1 Study

    https://www.globenewswire.com/news-release/2021/07/13/2262384/0/en/Madrigal-Pharmaceuticals-Offers-Patients-Resmetirom-in-a-Planned-Open-Label-Active-Treatment-Extension-of-the-Phase-3-MAESTRO-NAFLD-1-Clinical-Study.html

    GLOBENEWSWIRE
    13 Jul 2021
    Share Share
    Cholesterol & Triglyceride Abnormalities on a Rise, Driving Dyslipidemia Drugs
    Cholesterol & Triglyceride Abnormalities on a Rise, Driving Dyslipidemia Drugs

    https://www.prnewswire.com/news-releases/cholesterol-and-triglyceride-abnormalities-on-a-rise-driving-dyslipidemia-drugs-market-to-higher-trajectory-tmr-301024637.html

    PR NEWSWIRE
    16 Mar 2020
    Share Share
    Australian watchdog appeals to high court on Pfizer's alleged abuse of market
    Australian watchdog appeals to high court on Pfizer's alleged abuse of market

    https://www.reuters.com/article/us-australia-pfizer/australian-watchdog-appeals-to-high-court-on-pfizers-alleged-abuse-of-market-power-idUSKBN1JL0FL

    Sonali Paul REUTERS
    26 Jun 2018
    Share Share
    Older adults might be able to stave off arthritis knee pain with fiber
    Older adults might be able to stave off arthritis knee pain with fiber

    http://www.reuters.com/article/us-health-arthritis-fiber-idUSKBN18M1VQ

    Anne Harding REUTERS
    30 May 2017
    Share Share
    Amgen's Repatha Approved As First PCSK9 Inhibitor In Japan For Cholesterol
    Amgen's Repatha Approved As First PCSK9 Inhibitor In Japan For Cholesterol

    http://www.prnewswire.com/news-releases/amgens-repatha-evolocumab-approved-as-first-pcsk9-inhibitor-in-japan-for-the-treatment-of-high-cholesterol-300208360.html

    PR NEWSWIRE
    21 Jan 2016
    Share Share
    Paracetamol Risk To Unborn Boys, University of Edinburgh Study
    Paracetamol Risk To Unborn Boys, University of Edinburgh Study

    http://www.biospace.com/news_story.aspx?StoryID=378086&full=1

    BIOSPACE
    21 May 2015
    Share Share
    Hot Saunas Linked to Better Heart Health
    Hot Saunas Linked to Better Heart Health

    http://www.wsj.com/articles/hot-saunas-linked-to-better-heart-health-1425317034

    Ann Lukits THE WALL STREET JOURNAL
    04 Mar 2015
    Share Share
    No, The New Cholesterol Drugs From Sanofi And Amgen Aren't Going To Cost $150 Billion A Year
    No, The New Cholesterol Drugs From Sanofi And Amgen Aren't Going To Cost $150 Billion A Year

    http://www.forbes.com/sites/larryhusten/2015/02/18/no-the-new-cholesterol-drugs-from-sanofi-and-amgen-arent-going-to-cost-150-billion-a-year/

    Larry Husten FORBES
    18 Feb 2015
    Share Share
    Researchers Say When You Eat Each Day May Be Crucial to Weight Loss
    Researchers Say When You Eat Each Day May Be Crucial to Weight Loss

    http://www.wsj.com/articles/researchers-say-when-you-eat-each-day-may-be-crucial-to-weight-loss-1422901628

    Angela Chen THE WALL STREET JOURNAL
    02 Feb 2015
    Share Share
    8 Invented Diseases Big Pharma Is Banking On
    8 Invented Diseases Big Pharma Is Banking On

    http://www.alternet.org/personal-health/8-invented-diseases-big-pharma-banking

    Martha Rosenberg ALTERNET
    02 Feb 2015
    Share Share
    Start Worrying About Cholesterol In Your 30s, Study Suggests
    Start Worrying About Cholesterol In Your 30s, Study Suggests

    http://in.reuters.com/article/2015/01/27/us-midlife-cholesterol-statin-idINKBN0L02U220150127

    Andrew M Seaman REUTERS
    28 Jan 2015
    Share Share
    Amgen Banking On Three Launches In 2015
    Amgen Banking On Three Launches In 2015

    http://www.pmlive.com/pharma_news/amgen_banking_on_three_launches_in_2015_638496

    Phil Taylor PMLIVE
    28 Jan 2015
    Share Share
    High Cholesterol in 30s, 40s, Increases Later Risk of Heart Disease
    High Cholesterol in 30s, 40s, Increases Later Risk of Heart Disease

    http://www.sciencedaily.com/releases/2015/01/150126161730.htm

    SCIENCE DAILY
    26 Jan 2015
    Share Share
    US Priority Review for Sanofi/Regeneron Cholesterol Drug
    US Priority Review for Sanofi/Regeneron Cholesterol Drug

    http://www.pharmatimes.com/Article/15-01-26/US_priority_review_for_Sanofi_Regeneron_cholesterol_drug.aspx

    Selina Mckee PHARMA TIMES
    26 Jan 2015
    Share Share
    Researchers in Italy Found Bergamot Lowered Blood Cholesterol
    Researchers in Italy Found Bergamot Lowered Blood Cholesterol

    http://www.wsj.com/articles/researchers-in-italy-found-bergamot-lowered-blood-cholesterol-1421703338

    Laura Johannes THE WALL STREET JOURNAL
    20 Jan 2015
    Share Share
    After Roiling Hepatitis Market, Express Scripts Turns to Cholesterol
    After Roiling Hepatitis Market, Express Scripts Turns to Cholesterol

    http://www.bloomberg.com/news/2015-01-13/after-roiling-hepatitis-market-express-scripts-eyes-cholesterol.html

    Drew Armsrong And Caroline Chen BLOOMBERG
    14 Jan 2015
    Share Share
    Pfizer Developing PCSK9 Pill, Vaccine to Lower Cholesterol
    Pfizer Developing PCSK9 Pill, Vaccine to Lower Cholesterol

    http://in.reuters.com/article/2015/01/13/us-healthcare-pfizer-cholesterol-idINKBN0KM27A20150113

    Deena Beasley REUTERS
    14 Jan 2015
    Share Share
    Statin Drugs Cause Brain Dysfunction. Multibillion Dollar Profits for Big Pharma
    Statin Drugs Cause Brain Dysfunction. Multibillion Dollar Profits for Big Pharma

    http://www.globalresearch.ca/statin-drugs-cause-brain-dysfunction-multibillion-dollar-profits-for-big-pharma/5421483

    David Brownstein GLOBAL RESEARCH
    25 Dec 2014
    Share Share
    Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol
    Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol

    http://files.shareholder.com/downloads/REGN/3731868634x0x799520/ec830939-accc-4a57-bdd1-a2655b290054/REGN_News_2014_12_15_General_Releases.pdfof-cholesterol-300009297.html

    Press Release Regeneron
    15 Dec 2014
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    Nippon Cholesterol RM

    Access Virtual Booth

    Contact Supplier

    View Presentation

    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search